发明名称 |
Prevention and treatment of amyloidogenic disease |
摘要 |
Provided is an amyloid A-beta fragment linked to a carrier peptide for use in inducing an immune response against A-beta and thereby preventing or treating a disease associated with amyloid deposits of A-beta in the brain of a patient, wherein the A-beta fragment consists of: 5 i) A-beta1-7 having the amino acid sequence DAEFRHD ii) A-beta3-7 having the amino acid sequence EFRHD, or iii) a multimer of i) or ii). Further provided are pharmaceutical compositions comprising the peptide and use of the peptide fragments in the manufacture of a medicament to induce an immune response against A-beta and thereby prevent or treat an associated disease.
|
申请公布号 |
NZ570086(A) |
申请公布日期 |
2009.12.24 |
申请号 |
NZ20000570086 |
申请日期 |
2000.05.26 |
申请人 |
ELAN PHARMA INTERNATIONAL LIMITED |
发明人 |
SCHENK, DALE B;BARD, FREDERIQUE;VASQUEZ, NICKI;YEDNOCK, TED |
分类号 |
A61K39/395;A61K38/00;G01N33/50 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|